Dorsal root ganglia volume differentiates schwannomatosis and neurofibromatosis 2

Schwannomatosis and neurofibromatosis type 2 are hereditary tumor syndromes, and peripheral neuropathy has been reported in both. We prospectively applied in vivo morphometric measurement of dorsal root ganglia volume in 16 schwannomatosis patients, 14 neurofibromatosis type 2 patients, and 26 healt...

Full description

Saved in:
Bibliographic Details
Main Authors: Godel, Tim (Author) , Schwarz, Daniel (Author) , Kronlage, Moritz (Author) , Heiland, Sabine (Author) , Bendszus, Martin (Author) , Bäumer, Philipp (Author)
Format: Article (Journal)
Language:English
Published: 22 February 2018
In: Annals of neurology
Year: 2018, Volume: 83, Issue: 4, Pages: 854-857
ISSN:1531-8249
DOI:10.1002/ana.25191
Online Access:Verlag, Volltext: https://doi.org/10.1002/ana.25191
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.25191
Get full text
Author Notes:Tim Godel, Victor-Felix Mautner, Said Farschtschi, Mirko Pham, Daniel Schwarz, Moritz Kronlage, Isabel Gugel, Sabine Heiland, Martin Bendszus, and Philipp Bäumer
Description
Summary:Schwannomatosis and neurofibromatosis type 2 are hereditary tumor syndromes, and peripheral neuropathy has been reported in both. We prospectively applied in vivo morphometric measurement of dorsal root ganglia volume in 16 schwannomatosis patients, 14 neurofibromatosis type 2 patients, and 26 healthy controls by magnetic resonance neurography. Compared to healthy controls, dorsal root ganglia hypertrophy was a consistent finding in neurofibromatosis type 2 (L3, + 267%; L4, + 235%; L5, + 241%; S1, + 300%; S2, + 242%; Bonferroni-adjusted p < 0.001) but not in schwannomatosis. Dorsal root ganglia may be a vulnerable site in origination of areflexia and sensory loss and a useful diagnostic marker in neurofibromatosis type 2.
Item Description:Gesehen am 08.05.2019
Physical Description:Online Resource
ISSN:1531-8249
DOI:10.1002/ana.25191